Xenon Pharmaceuticals Inc

Xenon is a privately held company located in Vancouver and has just over 70 employees.
We are a leader in clinical genetic based drug discovery and development and have built a worldwide network of over 40 clinical collaborators to find and access the rare families with diseases of relevance to drug discovery. Our clinical genetic approaches are:

Extreme Genetics TM: the analysis of rare families that have multiple cases of a severe (extreme) clinical picture of a common disease with unmet medical need.
Opposite Phenotype: the analysis of rare genetic disorders, which have the opposite clinical features to a common disease.
Genetically Modified Models: Xenon creates novel in vivo models representative of human disease through utilizing loss-of-function (knockout) and over-expression (transgenic) strategies.

Contact Details: 3650 Gilmore Way Burnaby British Columbia V5G 4W8 Canada Tel: 604.484.3300 Fax: 604.484.3450 Email: info@xenon-pharma.com WWW: www.xenongenetics.com/

Loading...

Recent Publications by Xenon Pharmaceuticals Inc:
Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Congenital indifference to pain (CIP) is a rare condition in which...	22nd June, 2007	Xenon Pharmaceuticals Inc., 3650 Gilmore Way, Burnaby, BC V5G4W8, Canada.	Clin Genet. 2007 Apr;71(4):311-9. DOI Direct Link
Dopamine D1-like receptor modulates layer- and frequency-specific short-term synaptic plasticity in rat prefrontal cortical neurons. The mesocortical dopamine (DA) input to the prefrontal cortex (PFC) is...	15th September, 2005	Drug Discovery, Xenon Pharmaceuticals Inc., 3650 Gilmore Way, Burnaby, BC,	Eur J Neurosci. 2005 Jun;21(12):3310-20. DOI Direct Link

BioNews Results for Xenon Pharmaceuticals Inc:
Upstream Biosciences Appoints Dr. Michael Hayden Killam Professor of Medical Genetics and the Canada	Interest!ALERT:  Oct 2 2008 4:07AM Matching: xenon pharmaceuticals inc
Upstream Biosciences Appoints Dr. Michael Hayden Killam Professor of Medical Genetics and the Canada Research	Earthtimes.org:  Oct 1 2008 1:42PM Matching: xenon pharmaceuticals inc
Upstream Biosciences Appoints Dr. Michael Hayden Killam Professor of Medical Genetics and the Canada Research	Macro World Investor:  Oct 1 2008 1:17PM Matching: xenon pharmaceuticals inc
Upstream Biosciences Appoints Dr. Michael Hayden Killam Professor of Medical Genetics and the Canada Research	Calibre Macro World:  Oct 1 2008 1:02PM Matching: xenon pharmaceuticals inc

Xenon Pharmaceuticals Inc Patents:
US Patent No.	Title
7390813	Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents
7335658	Pyridazine derivatives and their use as therapeutic agents
7297523	Human elongase genes and uses thereof
7294480	High throughput screening assays using fatty acid synthetic enzymes
7232662	Methods and compositions employing a novel stearoyl-CoA desaturase-hSCD5
→View more Xenon Pharmaceuticals Inc patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 213 times since April 2007, the link to the organisation's website has been followed 41 times

Recent Search Terms used to find this page: xenon pharmaceuticals | Xenon Pharma videos | .

Search for more companies in Burnaby

Search for more companies in British Columbia

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Xenon Pharmaceuticals Inc